 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
April 26, 2024
Reassessed
- Epigenetics of autoimmune disorders ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)
April 25, 2024
Reassessed
- Compound heterozygosity ( talk) reassessed. Quality rating changed from B-Class to C-Class. ( rev · t)
April 24, 2024
Assessed
- Epigenetics of autoimmune disorders ( talk) assessed. Quality assessed as Unassessed-Class. ( rev · t) Importance assessed as Unknown-Class. ( rev · t)
April 23, 2024
Assessed
| This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
April 26, 2024
Reassessed
- Epigenetics of autoimmune disorders ( talk) reassessed. Quality rating changed from Unassessed-Class to C-Class. ( rev · t)
April 25, 2024
Reassessed
- Compound heterozygosity ( talk) reassessed. Quality rating changed from B-Class to C-Class. ( rev · t)
April 24, 2024
Assessed
- Epigenetics of autoimmune disorders ( talk) assessed. Quality assessed as Unassessed-Class. ( rev · t) Importance assessed as Unknown-Class. ( rev · t)